Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2020

Oct 7, 2020

29745_dirs_2020-10-07_8ec4bcdd-4e56-4d18-a6eb-fc7b087315fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-10-04

Reporting Person: Yuffa Ilya (SVP and Pres, Lilly Bio-Meds)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6813 Direct